These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6574949)
1. Multimarker analysis of childhood acute lymphoblastic leukemia (ALL): heterogeneity of cellular phenotypes and clinical relevance of immunological defined ALL subclasses. Thoene I; Kabisch H Haematol Blood Transfus; 1983; 28():126-30. PubMed ID: 6574949 [No Abstract] [Full Text] [Related]
2. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies. Zipf TF; Fox RI; Dilley J; Levy R Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Greaves MF Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of immunological and cytochemical profiles between adult and childhood acute lymphoblastic leukemias (ALLs): heterogeneity in adult common ALL. Kuriyama K; Tomonaga M; Nonaka H; Jinnai I; Matsuo T; Yoshida Y; Amenomori T; Tagawa M; Ichimaru M; Ohmiya A Leuk Res; 1985; 9(10):1237-47. PubMed ID: 2933563 [TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of monoclonal-antibody phenotyping in childhood acute lymphoblastic leukemia. Kersey J; Goldman A; Abramson C; Nesbit M; Perry G; Gajl-Peczalska K; LeBien T Lancet; 1982 Dec; 2(8313):1419-23. PubMed ID: 6129506 [TBL] [Abstract][Full Text] [Related]
11. Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia of childhood. Pullen DJ; Falletta JM; Crist WM; Vogler LB; Dowell B; Humphrey GB; Blackstock R; Eys JV; Cooper MD; Metzgar RS; Meydrech EF Cancer Res; 1981 Nov; 41(11 Pt 2):4802-9. PubMed ID: 6975163 [No Abstract] [Full Text] [Related]
12. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes. van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114 [TBL] [Abstract][Full Text] [Related]
14. [Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies]. Gómez Morales M; De Andrés MA; Garrido ML; Delgado C; Cabrera A; Garrido F Sangre (Barc); 1985; 30(3):348-54. PubMed ID: 3929410 [No Abstract] [Full Text] [Related]
15. [Characteristics of the immunological subvariants of acute lymphoblastic leukemia in children]. Baryshnikov AIu; Lenskaia RV; Kondratchik KL; Tupitsyn NN; Baĭdun LV Gematol Transfuziol; 1987 Feb; 32(2):26-31. PubMed ID: 3493944 [No Abstract] [Full Text] [Related]
16. Biological and clinical significance of immunological cell markers in leukemia. Thiel E Recent Results Cancer Res; 1984; 93():102-58. PubMed ID: 6382477 [No Abstract] [Full Text] [Related]
17. [Acute lymphoblastic leukemia and HLA]. Qian FW; Ye GY; Kong FH Zhonghua Nei Ke Za Zhi; 1986 Apr; 25(4):217-9, 253-4. PubMed ID: 3461930 [No Abstract] [Full Text] [Related]
18. HLA DR antigens in childhood acute lymphoblastic leukaemia long survival. De Bruyere M; Cornu G; Ninane J; Latinne D; Lebacq AM; Sokal G Br J Haematol; 1982 Aug; 51(4):659-61. PubMed ID: 6980667 [No Abstract] [Full Text] [Related]
19. [A case of acute leukemia with lympho- and myeloblastic blast cell characteristics]. Tupitsyn NN; Baryshnikov AIu; Makhonova LA; Peterson IS; Morozova LF Gematol Transfuziol; 1984 Aug; 29(8):49-54. PubMed ID: 6332760 [No Abstract] [Full Text] [Related]